Digital assets totaled $5.2M as of September 30, 2025, compared to $0.8M as of December 31, 2024. The company said, “The Company continues to maintain a strong balance sheet while achieving cost control and reducing overhead and burn rate compared to prior quarters. Management believes there is sufficient cash on hand to sustain operations beyond March 2027.”
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on QNTM:
- Quantum Biopharma Reports Q3 2025 Financial Results
- Quantum BioPharma Initiates $21.2 Million ATM Offering to Boost R&D
- Quantum BioPharma Highlights Growth at ArcStone-Kingswood Summit
- Quantum BioPharma Ltd. Files October 2025 Form 6-K with SEC
- Quantum Biopharma Ltd. Files October 2025 Form 6-K Reflecting Strategic Developments